RedHill Biopharma Ltd.
RedHill Biopharma Ltd. (RDHL): 2 pipeline candidates · 2 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
D/E -5.16 · 0% dilution
Lead: Phase 2/Phase 3
2 candidates
N/A
0 buys · 1 sell (180d)
A transparent, data-derived signal for RedHill Biopharma Ltd.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$4.2M
Cash
$2.9M
Quarterly Burn
—
Runway
—
Revenue
—
Pipeline (2 candidates)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
14
Total value held
$124K
| Holder | Shares | Value |
|---|---|---|
| gagnon securities llc | 88,405 | $66K |
| citadel advisors llc | 20,673 | $15K |
| xtx topco ltd | 15,163 | $11K |
| stonex group inc. | 14,481 | $11K |
| two sigma securities, llc | 13,019 | $10K |
| gamma investing llc | 6,684 | $5K |
| rhumbline advisers | 5,116 | $4K |
| federation des caisses desjardins du quebec | 3,388 | $3K |
| your advocates ltd., llp | 19 | $14 |
| smartleaf asset management llc | 5 | $4 |
Showing top 10 of 14 institutional holders of RedHill Biopharma Ltd.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in RedHill Biopharma Ltd.'s pipeline?
RedHill Biopharma Ltd. (RDHL) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is RedHill Biopharma Ltd.'s lead drug candidate?
RedHill Biopharma Ltd.'s most advanced tracked candidate is abc294640 (Phase 2) for Cholangiocarcinoma.
What is RedHill Biopharma Ltd.'s market capitalization?
RedHill Biopharma Ltd.'s market capitalization is approximately $4.2M.
Who is the CEO of RedHill Biopharma Ltd.?
Mr. Dror Ben-Asher is the chief executive officer of RedHill Biopharma Ltd. (RDHL).
Get the full picture on RedHill Biopharma Ltd.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.